Study guide
10.2 Pathology Reporting, CAP Cancer Protocols & Electronic Pathology (CoC Standard 5.1)
NCRA Oncology Data Specialist ODS-C
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: The ODS-C Exam, the Oncology Data Specialist Profession & Standard Setters
1.1 ODS Exam Structure, Timing, Scoring & 2026 Testing Windows 1.2 From CTR to ODS: The Credential, Eligibility Routes & the Registrar's Role 1.3 Standard-Setting Organizations & the Manuals They Publish
2 Chapter 2: Legal Framework, HIPAA & State Reporting Laws
2.1 HIPAA Privacy Rule & the Public Health Reporting Exception 2.2 HIPAA Security Rule, Safeguards & Breach Notification 2.3 State Mandatory Cancer Reporting Laws & Statutory Authority
3 Chapter 3: Confidentiality, Release of Information, Ethics & Credential Maintenance
3.1 Patient Confidentiality Protocols & Data Access Policies 3.2 Handling Subpoenas, Discovery & Registry Immunity Statutes 3.3 NCRA Code of Ethics & ODS Credential Maintenance
4 Chapter 4: Registry Organization, Staffing & Information Systems
4.1 Types of Cancer Registries, Their Functions & Registry Operating Protocols 4.2 Registry Staffing Formulas, Time Studies & Resource Allocation 4.3 Electronic Registry Systems, Security & Disaster Recovery Planning
5 Chapter 5: Cancer Committee, Cancer Conferences & Quality Improvement
5.1 The Cancer Committee: CoC Standards 2.1–2.4, the CLP & Annual Program Activities 5.2 Multidisciplinary Cancer Case Conferences (CoC Standard 2.5) 5.3 Quality Improvement Principles & CoC Chapter 7 (Standards 7.1–7.3)
6 Chapter 6: CoC Accreditation Standards, NCDB & Data Quality
6.1 CoC Accreditation: Standards Structure, Program Categories & Accreditation Awards 6.2 The National Cancer Database (NCDB), RCRS Submission & CoC Quality Measures 6.3 Quality Control Plans & Audit Techniques (CoC Standard 6.1)
7 Chapter 7: Surveillance Programs, NAACCR Standards, Epidemiology & Statistics
7.1 National Cancer Surveillance Programs: SEER & CDC NPCR 7.2 NAACCR Data Exchange Standards, XML Data Specifications & Registry Certification 7.3 Basic Cancer Epidemiology & Descriptive Statistics 7.4 Basic Statistics: Frequency Distributions, Central Tendency, Risk Ratios & Odds Ratios 7.5 Survival Analysis, Life Tables & Presentation of Registry Data
8 Chapter 8: Medical Terminology, Anatomy & Types of Cancer
8.1 Medical Terminology & Standard Abbreviations for Cancer Abstracting 8.2 Human Anatomy & Physiology for Registrars: Tissues, Organ Walls, Subsites & Lymphatic Drainage 8.3 Types & Characteristics of Cancer: Benign vs. Malignant, Tumor Families, Spread & Precursors
9 Chapter 9: Casefinding & Reportability
9.1 Principles of Casefinding & Facility Reference Dates 9.2 Casefinding Sources: Pathology, Cytology, Disease Index & Logs 9.3 Reportability: What CoC, SEER and NPCR Require, Including Non-Malignant CNS Tumors 9.4 Ambiguous Terminology: Reportable Terms, Cytology, Discrepancies & "References of Last Resort"
10 Chapter 10: Diagnostic Procedures, Pathology Reporting, Lab Methods & Prognostic Indicators
10.1 Diagnostic & Staging Procedures: Imaging, Endoscopy, Biopsy & How They Are Coded 10.2 Pathology Reporting, CAP Cancer Protocols & Electronic Pathology (CoC Standard 5.1) 10.3 Specialty Laboratory Testing Methods: IHC, FISH, PCR/RT-PCR, NGS, Flow Cytometry & Cytogenetics 10.4 Prognostic Indicators & Site-Specific Data Items (SSDIs): HPV, KRAS, HER2 and More
11 Chapter 11: Class of Case, Key Dates & Case Identifiers
11.1 Class of Case, Date of First Contact, Date of Diagnosis & Accession/Sequence Numbers 11.2 Analytic Classes of Case (00, 10–14, 20–22): Definitions & Decision Rules 11.3 Nonanalytic Classes of Case (30–49, 99) & Why Central Registries Need Them
12 Chapter 12: Follow-Up, Vital Status & Recurrence
12.1 Follow-Up Purpose, Active & Passive Methods, and Follow-Up Source Codes 12.2 CoC Standard 6.5 Follow-Up Rates: Windows, Exclusions & Calculations 12.3 Vital Status, Date of Last Contact, Cancer Status & Death Clearance 12.4 Recurrence: Type of First Recurrence [1880], Date of First Recurrence [1860] & Recurrence vs. New Primary
13 Chapter 13: Abstracting, ICD-O-3.2 Site & Histology Coding, and Grade
13.1 The Abstracting Process: Workflow, Source Documents, Timeliness & Text Documentation 13.2 ICD-O-3.2 Topography, Primary Site Rules & Laterality 13.3 ICD-O-3.2 Morphology: Histology, Behavior & the Solid Tumor Histology Rules 13.4 Grade: The Four Time-Specific Grade Items & Site-Specific Grade Tables
14 Chapter 14: Solid Tumor Rules & Hematopoietic Coding Rules
14.1 Solid Tumor Rules: Purpose, Site Groups, Navigation & Timing Principles 14.2 Solid Tumor Rules for Breast, Colon/Rectum & Lung: The Multiple Primary Rules in Order 14.3 Solid Tumor Rules for Head & Neck, Kidney, Urinary, CNS, Melanoma & Other Sites 14.4 Hematopoietic & Lymphoid Neoplasms: Heme Manual, Heme DB, Multiple Primary & Primary Site Rules
15 Chapter 15: Staging: AJCC TNM (8th Edition & Version 9 Lung) and Summary Stage 2018
15.1 AJCC TNM Principles: Categories, Prefixes, Suffixes, General Rules & Registry Items 15.2 AJCC Time Frames: Clinical, Pathological, Post-Therapy (yc, yp), Recurrence & Autopsy 15.3 Breast Staging (AJCC 8th Edition, Part XI): T, N, M, Anatomic & Prognostic Stage Groups 15.4 Lung Staging (AJCC Version 9, 2025+): T, N2a/N2b, M1c1/M1c2 & New Stage Groups 15.5 Male Genital & Urinary Tract Staging (AJCC 8th Parts XIII–XIV): Prostate, Testis, Kidney, Bladder, Renal Pelvis & Ureter 15.6 SEER Summary Stage 2018: Codes, Timing, General Rules & Site Examples
16 Chapter 16: First-Course Treatment Coding (STORE 2025) & EDITS
16.1 Treatment Types, First Course of Treatment & Evidence-Based Guidelines (NCCN) 16.2 Surgery Coding: Rx Summ–Surg 2023 [1291], Lymph Node Surgery [1292], Other Site [1294], Margins & Reason for No Surgery 16.3 Radiation, Systemic, Transplant, Other & Palliative Treatment Coding (STORE 2025) 16.4 NAACCR EDITS, Over-ride Flags & Data Validation
10.2 Pathology Reporting, CAP Cancer Protocols & Electronic Pathology (CoC Standard 5.1)
Key Takeaways Explain This Topic AI
A surgical pathology report typically contains clinical history, gross description, microscopic description, final diagnosis, a synoptic (CAP) summary, comments, addenda and ancillary study results.
The Solid Tumor Rules say to use the more specific histology when the final diagnosis and the synoptic report disagree; the CAP protocol itself is used only when neither is available. STORE ranks lymph node counts as final diagnosis, synoptic report, microscopic, then gross.
CAP cancer protocols list core and conditional data elements to be reported in "diagnostic parameter pair" format (element followed by its response), grouped together in one place in the report.
CoC Standard 5.1 requires an annual clinician audit of at least 20 eligible resection reports from at least three disease sites, confirming that at least 90% use CAP synoptic format with all core elements.
Eligible reports are definitive resections of invasive primary cancers and DCIS, and resections after neoadjuvant therapy with residual tumor; biopsies, cytology and resections with no residual tumor are not required to use the protocol.
Last updated: September 2026
Why pathology reporting is a separate topic
Most reportable cancers are microscopically confirmed, and the pathology report supplies the codes that matter most: histology and behavior, grade, tumor size and extension, margins, lymph nodes, lymphovascular invasion and many SSDIs. The ODS outline lists "pathology reporting" in Domain 3 and names CAP among the organizations in Domain 2.
Anatomy of a surgical pathology report
Section Contents Registry use
Specimen and clinical information Procedure, laterality, clinical history Confirms the site, laterality, and whether neoadjuvant therapy was given
Gross description What the pathologist saw and measured: size, cut surfaces, margin distances, node count Tumor size when the microscopic size is not given; lowest priority for node counts
- Microscopic description Histologic findings Supports the histology and extent
- Final diagnosis The pathologist's conclusion Primary source for histology and behavior
Synoptic report or CAP summary Structured list of core elements Often the most specific source for histology, grade, margins, lymph nodes and pTNM
Comment Differential diagnosis, reasoning Context; watch for ambiguous terms
Addendum or amended report New or corrected information (IHC, molecular results, revised diagnosis) Update the abstract
Consultation report Outside expert review For grade, the Grade Manual says to record the consult result when it differs from the original
Which part to trust when parts disagree
Histology: the Solid Tumor Rules say that when the final diagnosis and the synoptic report differ, use the document with the more specific histology , which is usually the synoptic report. Use the CAP protocol only when a final diagnosis or synoptic report is not available. Each site module also gives its own priority order for pathology, cytology, imaging and physician documentation. Tissue pathology always comes first.
Regional lymph node counts: STORE's priority is final diagnosis → synoptic report (CAP protocol or checklist) → microscopic → gross .
Grade: the Grade Manual's priority is synoptic report (including the CAP protocol) → final diagnosis → physician statement .
Neoadjuvant therapy: code histology from the diagnosis made before neoadjuvant therapy, because treatment can change the tumor's appearance.
The CAP Cancer Protocols
The College of American Pathologists (CAP) publishes cancer protocols (templates) for each site and procedure. They define:
Core elements , which must be reported whether or not they apply, and conditional elements , which are reported only when applicable.
"Diagnostic parameter pair" format: each element is followed by its response (for example, "Margins: negative for invasive carcinoma").
Layout: each pair on its own line or in a table, with all core elements together in one location.
Typical core elements for a resection include the procedure, tumor site, histologic type, histologic grade, tumor size, extent of invasion, margins, lymphovascular invasion, regional lymph nodes (number examined and number with metastasis), and a pathologic stage classification. Biomarker results are often reported in separate CAP biomarker templates.
The pathologist's pTNM in the synoptic report is valuable, but the registry's AJCC stage is assigned by applying AJCC rules to all the information in the pathologic time frame. That may add information the pathologist did not have, such as a biopsy-proven distant metastasis.
CoC Standard 5.1: College of American Pathologists Synoptic Reporting
Requirement Detail
Annual internal audit Confirms that at least 90% of eligible cancer pathology reports use CAP synoptic format with all core elements
- Sample At least 20 surgical resection cases from at least three different disease sites
- Auditor A clinician ; a pathologist is recommended but not required
Reporting Results are presented to the cancer committee in the same calendar year and documented in the minutes
Below 90% An action plan to find and remove the barriers
Eligible reports:
Definitive surgical resections of primary invasive malignancies and of DCIS .
Definitive surgical resections after neoadjuvant therapy when residual tumor remains.
Not required to use the CAP protocol:
Definitive resections with no residual tumor .
Additional procedures after the definitive resection (for example, re-excision of positive margins, or later node biopsy or resection).
Diagnostic biopsies, cytology or other diagnostic procedures done before definitive surgery.
Resections for recurrent tumor.
In situ carcinomas other than DCIS .
Special studies such as biomarker or prognostic testing.
Electronic pathology (e-path) reporting
Pathology laboratories send structured results electronically in HL7 messages, following NAACCR's standard for pathology laboratory electronic reporting ( Standards for Cancer Registries, Volume V ). CAP's electronic Cancer Checklists (eCC) let pathologists capture synoptic data discretely.
Hospital registries use e-path feeds for casefinding . Automated keyword screening flags reports that a registrar then reviews, because "negative for carcinoma" also contains the word "carcinoma."
Central registries receive e-path directly from independent and hospital laboratories. This improves completeness and timeliness, especially for cases diagnosed outside hospitals. Pathology-only reports may be collected (Class of Case 43 where required) and followed back to physicians.
Reading a synoptic report: example
Colon, right hemicolectomy. Histologic type: adenocarcinoma. Grade: G2 (moderately differentiated). Tumor size: 4.8 cm. Extent: invades through the muscularis propria into pericolonic tissue. Margins: all negative. LVI: present. Regional nodes: 2 of 17 involved. Tumor deposits: not identified. pTNM: pT3 pN1b.
The registrar codes adenocarcinoma 8140/3; Grade Pathological 2 (following the Grade Manual colorectal table); Regional Nodes Examined 17 and Positive 02; Tumor Deposits 00. The AJCC pathologic stage is assigned after confirming the M category from the whole record, for example cM0 from imaging.